{"id":"https://openalex.org/W1968657539","doi":"https://doi.org/10.1016/j.ymthe.2006.08.972","title":"883. AAV-2 Based Gene Therapy Using Novel Anti-VEGF Molecules for Inhibition of Angiogenesis in the Eye","display_name":"883. AAV-2 Based Gene Therapy Using Novel Anti-VEGF Molecules for Inhibition of Angiogenesis in the Eye","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W1968657539","doi":"https://doi.org/10.1016/j.ymthe.2006.08.972","mag":"1968657539"},"language":"en","primary_location":{"id":"doi:10.1016/j.ymthe.2006.08.972","doi":"https://doi.org/10.1016/j.ymthe.2006.08.972","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.972","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ymthe.2006.08.972","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072582941","display_name":"Abraham Scaria","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abraham Scaria","raw_affiliation_strings":["Molecular Biology, Genzyme Corporation, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology, Genzyme Corporation, Framingham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041399608","display_name":"Peter A. Pechan","orcid":"https://orcid.org/0000-0001-9663-8743","observed_orcids":["https://orcid.org/0000-0001-9663-8743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Pechan","raw_affiliation_strings":["Molecular Biology, Genzyme Corporation, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology, Genzyme Corporation, Framingham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113593366","display_name":"Hillard L. Rubin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hillard Rubin","raw_affiliation_strings":["Molecular Biology, Genzyme Corporation, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology, Genzyme Corporation, Framingham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090090588","display_name":"Michael Lukason","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Lukason","raw_affiliation_strings":["Molecular Biology, Genzyme Corporation, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology, Genzyme Corporation, Framingham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102782202","display_name":"Elizabeth Barry","orcid":"https://orcid.org/0000-0002-6594-6230","observed_orcids":["https://orcid.org/0000-0002-6594-6230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Barry","raw_affiliation_strings":["Molecular Biology, Genzyme Corporation, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology, Genzyme Corporation, Framingham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046892194","display_name":"Jeffrey A. Ardinger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey Ardinger","raw_affiliation_strings":["Molecular Biology, Genzyme Corporation, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology, Genzyme Corporation, Framingham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062630759","display_name":"Huawei Qiu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huawei Qiu","raw_affiliation_strings":["Therapeutic Protein Research, Genzyme Corporation, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Protein Research, Genzyme Corporation, Framingham, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100701724","display_name":"Qiuhong Li","orcid":"https://orcid.org/0000-0003-4211-6514","observed_orcids":["https://orcid.org/0000-0003-4211-6514"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiuhong Li","raw_affiliation_strings":["Ophthalmology, University of Florida, Gainsville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, University of Florida, Gainsville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":null,"display_name":"James Peterson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Peterson","raw_affiliation_strings":["Ophthalmology, University of Florida, Gainsville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, University of Florida, Gainsville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086264524","display_name":"William W. Hauswirth","orcid":"https://orcid.org/0000-0002-3244-4947","observed_orcids":["https://orcid.org/0000-0002-3244-4947"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Hauswirth","raw_affiliation_strings":["Ophthalmology, University of Florida, Gainsville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, University of Florida, Gainsville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035364814","display_name":"Samuel C. Wadsworth","orcid":"https://orcid.org/0000-0002-9404-9328","observed_orcids":["https://orcid.org/0000-0002-9404-9328"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samuel Wadsworth","raw_affiliation_strings":["Molecular Biology, Genzyme Corporation, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology, Genzyme Corporation, Framingham, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.17095756,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":"S340","last_page":"S340"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.35519999265670776,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.35519999265670776,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.20180000364780426,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.1860000044107437,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vegf-neutralization","display_name":"VEGF neutralization","score":0.7139999866485596},{"id":"https://openalex.org/keywords/retinal-neovascularization","display_name":"retinal neovascularization","score":0.9419999718666077},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9160000085830688},{"id":"https://openalex.org/keywords/proliferative-diabetic-retinopathy","display_name":"proliferative diabetic retinopathy","score":0.9879999756813049},{"id":"https://openalex.org/keywords/oxygen-induced-retinopathy","display_name":"oxygen-induced retinopathy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/laser-induced-choroidal-neovascularization","display_name":"laser-induced choroidal neovascularization","score":0.9660000205039978},{"id":"https://openalex.org/keywords/intravitreal-gene-delivery","display_name":"intravitreal gene delivery","score":0.8870000243186951},{"id":"https://openalex.org/keywords/retinal-ganglion-cells","display_name":"retinal ganglion cells","score":0.8489999771118164},{"id":"https://openalex.org/keywords/transgene-expression-persistence","display_name":"transgene expression persistence","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.7414084672927856},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.701952338218689},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6902104616165161},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4514627754688263},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4452539086341858},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4012494385242462},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3493703603744507},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.32648804783821106},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13683250546455383}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.ymthe.2006.08.972","doi":"https://doi.org/10.1016/j.ymthe.2006.08.972","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.972","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.ymthe.2006.08.972","doi":"https://doi.org/10.1016/j.ymthe.2006.08.972","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.972","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2095577723","https://openalex.org/W4295021522","https://openalex.org/W1500640490","https://openalex.org/W4388011848","https://openalex.org/W4413137947","https://openalex.org/W4400526144","https://openalex.org/W2096454490","https://openalex.org/W4245056673","https://openalex.org/W2331634724","https://openalex.org/W2160297253"],"abstract_inverted_index":{"Vascular":[0],"endothelial":[1],"growth":[2],"factor":[3],"(VEGF)":[4],"plays":[5],"a":[6,14,46,149,241],"critical":[7],"role":[8],"in":[9,71,127,205,229,238,253,258],"pathological":[10],"neovascularization":[11],"which":[12],"is":[13,45,62],"key":[15],"component":[16],"of":[17,35,55,60,88,100,122,155,177,185,191,243,270],"ocular":[18,223],"diseases":[19],"like":[20],"wet":[21],"age-related":[22],"macular":[23],"degeneration":[24],"(AMD)":[25],"or":[26],"proliferative":[27],"diabetic":[28],"retinopathy":[29,235],"(PDR).":[30],"There":[31],"are":[32,80,267],"several":[33,72],"reports":[34],"preclinical":[36],"and":[37,78,86,137,174,213,246],"clinical":[38],"studies":[39],"that":[40,42,74,102,182,262],"demonstrate":[41],"antagonizing":[43],"VEGF":[44,61,64,106,117,134],"potentially":[47],"useful":[48],"strategy":[49],"for":[50,83,200,222],"treating":[51],"such":[52],"disorders.":[53],"One":[54],"the":[56,63,91,130,158,178,206],"most":[57],"potent":[58,268],"binders":[59,107],"receptor":[65],"Flt-1.":[66],"It":[67],"has":[68],"been":[69],"shown":[70],"publications":[73],"Flt-1":[75,101],"domains":[76],"2":[77,143],"3":[79],"both":[81,257],"required":[82],"efficient":[84],"binding":[85,109,135],"neutralization":[87],"VEGF.":[89],"In":[90,171],"current":[92],"study":[93],"we":[94,160],"have":[95,161],"engineered":[96],"soluble":[97],"hybrid":[98],"forms":[99],"represent":[103],"novel":[104,164,264],"high-affinity":[105],"with":[108],"affinities":[110],"comparable":[111],"to":[112,151,227],"other":[113],"known":[114],"high":[115],"affinity":[116],"binders.":[118],"The":[119,233],"biological":[120],"activity":[121],"these":[123,163,263],"constructs":[124],"was":[125,198],"determined":[126],"vitro":[128],"by":[129],"HUVECs":[131],"proliferation":[132],"assays,":[133],"assays":[136],"BIAcore":[138],"analysis.":[139],"Since":[140],"adeno-associated":[141],"virus":[142],"(AAV2)":[144],"mediated":[145,211],"gene":[146],"delivery":[147,154,212],"offers":[148],"means":[150],"achieve":[152],"local":[153],"proteins":[156],"into":[157,167],"eye":[159,180,208],"inserted":[162],"anti-VEGF":[165,265],"molecules":[166,266],"A":[168],"AV2":[169],"vectors.":[170],"situ":[172],"analysis":[173,176],"immunohistochemistry":[175],"mouse":[179,207],"show":[181],"intravitreal":[183],"administration":[184],"AAV2":[186,210],"based":[187],"vector":[188],"mediates":[189],"transduction":[190],"retinal":[192,244,271],"ganglion":[193],"cells.":[194],"Persistent":[195],"transgene":[196],"expression":[197],"observed":[199],"at":[201],"least":[202],"13":[203],"months":[204],"following":[209],"no":[214],"gross":[215],"transgene-related":[216],"toxicities":[217],"were":[218,225],"observed.":[219],"Two":[220],"models":[221,260],"angiogenesis":[224,245],"employed":[226],"access":[228],"vivo":[230,259],"efficacy":[231],"(1)":[232],"oxygen-induced":[234],"(OIR)":[236],"model":[237,242,252],"mice":[239],"as":[240],"(2)":[247],"Laser":[248],"induced":[249],"choroidal":[250],"neovasculaization":[251],"mice.":[254],"Data":[255],"from":[256],"suggests":[261],"inhibitors":[269],"neovascularization.":[272]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}